Preparing the Board for M&A and Managing an M&A process – Synthoryx
Chapter Co-Chair Carol Gallagher will moderate a panel discussion on how growth company boards can prepare for the M&A process. They will discuss the process by which local LaJolla-based company Synthorx was acquired for $2.5bln by French drugmaker Sanofi (NASDAQ:SNY) in December 2019, after having been in Series B $10mln capital-raising mode as recently as 2016. Laura Shawver, former CEO of Synthoryx, will give her perspective of how to work with a board for a successful exit. Vickie Capps will add her perspective as a Board Member of Synthoryx as an investor from Silverback Therapeutics. Ken Rollins, Partner at Cooley, will speak from the legal advisor perspective on the general topic of Board preparation for this type of M&A deal.
Vickie Capps is known for her exceptionally strong skill set consisting of executive leadership and mentoring, global strategic business development, corporate finance and accounting, capital markets and investor relations, operations, business integration/restructuring and corporate governance.
Vickie is currently a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare focused private equity firm. She is also a member of the board of directors and the audit committee chair of each of NuVasive, Inc., a public medical device company (Nasdaq:NUVA), Otonomy, Inc., a public biopharmaceutical company (Nasdaq:OTIC) and Amedisys, Inc., a public home health and hospice company (Nasdaq:AMED). Vickie is also a member of the Boards of Directors of Silverback Therapeutics, Inc., a private biopharmaceutical company, and OmniGuide, Inc., a private medical device company. She previously served as a member of the boards of directors of Synthorx, Inc. (Nasdaq), prior to its sale to Sanofi in January 2020, Enclara Pharmacia (Private), prior to its sale to Humana in January 2020, Connecture, Inc. (Nasdaq), prior to its being taken private by Francisco Partners in April 2018, RF Surgical Systems (Private) prior to its acquisition by Medtronic in August 2015 and SenoRx (Nasdaq), prior to its acquisition by C. R. Bard, Inc. in July 2010. She is also a member of the board of directors of the San Diego State University Research Foundation.
Vickie has had a distinguished career in finance and executive leadership. After she received her Bachelor of Science degree in Business Administration/Accounting from San Diego State University, she began her career with Ernst & Young LLP and served 10 years as a senior audit and accounting professional. Her subsequent work experience included CFO positions at several multinational corporations. Ms. Capps is a California Certified Public Accountant and was recognized as a CFO of the Year honoree by the San Diego Business Journal in 2009 and 2010.